Tokyo, Japan

Yutaka Takahashi

USPTO Granted Patents = 90 


 

Average Co-Inventor Count = 2.8

ph-index = 18

Forward Citations = 2,114(Granted Patents)


Inventors with similar research interests:


Location History:

  • Tokyo, JA (1977)
  • Kyoto, JA (1976 - 1978)
  • Hachioji, JP (1982 - 1993)
  • Kyoto, JP (1978 - 1997)
  • Nagano, JP (1999)
  • Hanamaki, JP (2000)
  • Esashi, JP (2005 - 2007)
  • Tokyo-to, JP (1996 - 2008)
  • Setagaya, JP (2008)
  • Setagaya-ku, JP (2009)
  • Kai, JP (2011)
  • Numazu, JP (2012)
  • Shizuoka, JP (2013)
  • Kanagawa-ken, JP (1998 - 2015)
  • Tokyo, JP (1978 - 2024)
  • Iwate, JP (2018 - 2024)

Company Filing History:


Years Active: 1976-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Composition
Film Deposition Method
Silicon Nitride Film
Image Forming Apparatus
Electrophotographic Method
NMR Spectrometer
Oxidation Method
Developing Agent
Toner Transport
Magnetic Recording Medium
Digital-Control Oscillator
Lifetime Management Device
90 patents (USPTO):Explore Patents

Title: Innovations by Yutaka Takahashi: A Pioneer in Pharmaceutical Patents

Introduction

Yutaka Takahashi, based in Tokyo, Japan, is a prolific inventor with an impressive portfolio of 85 patents. His contributions to the field of pharmaceuticals have played a significant role in advancing drug development and therapeutic applications.

Latest Patents

Among his latest innovations, Takahashi has developed a pharmaceutical composition for modified release. This includes a unique formulation comprising (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide, or a pharmaceutically acceptable salt thereof, accompanied by a carrier designed for a sustained release pharmaceutical composition. This invention ensures that the maximum blood drug concentration (Cmax) does not exceed 400 ng/ml when administered under fasting conditions.

Additionally, he has created a formulation that includes the aforementioned chemical compound, as well as an additive that facilitates water penetration into the pharmaceutical composition. This formulation features a hydrogel-forming polymer with high molecular weight, ensuring efficient drug delivery.

Career Highlights

Throughout his career, Takahashi has worked with notable companies in the technology and pharmaceutical sectors. He has been affiliated with Olympus Optical Company, Ltd. and Tokyo Electron Limited, where he has leveraged his expertise in innovation and research to contribute to the advancement of various projects. His innovation-driven approach has solidified his reputation as a key figure in his field.

Collaborations

Takahashi has had the opportunity to collaborate with talented professionals such as Hitoshi Kato and Kazumi Kubo. These collaborations have enriched his research endeavors and facilitated the successful development of his inventions.

Conclusion

Yutaka Takahashi's contributions to the field of pharmaceuticals through his 85 patents highlight his commitment to innovation and the development of advanced drug formulations. His work demonstrates the significant impact that dedicated inventors can have on healthcare and medical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…